Iris Unimi Prodmetadata only
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
hcc, alpha-fetoprotein, atezolizumab plus bevacizumab, eosinophil, lenvatinib, settore meds-10/a - gastroenterologia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 340177
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.